Bank of New York Mellon’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $399K | Hold |
|
|||||
|
2021
Q4 | $373K | Buy |
|
|||||
|
2021
Q3 | $739K | Buy |
|
|||||
|
2021
Q2 | $1.16M | Sell |
|
|||||
|
2021
Q1 | $1.59M | Buy |
|
|||||
|
2020
Q4 | $1.21M | Buy |
|
|||||
|
2020
Q3 | $1.44M | Sell |
|
|||||
|
2020
Q2 | $1.15M | Sell |
|
|||||
|
2020
Q1 | $13.4M | Sell |
|
|||||
|
2019
Q4 | $31.7M | Sell |
|
|||||
|
2019
Q3 | $56.2M | Sell |
|
|||||
|
2019
Q2 | $55M | Sell |
|
|||||
|
2019
Q1 | $118M | Sell |
|
|||||
|
2018
Q4 | $116M | Buy |
|
|||||
|
2018
Q3 | $199M | Sell |
|
|||||
|
2018
Q2 | $190M | Sell |
|
|||||
|
2018
Q1 | $158M | Buy |
|
|||||
|
2017
Q4 | $175M | Buy |
|
|||||
|
2017
Q3 | $137M | Buy |
|
|||||
|
2017
Q2 | $121M | Buy |
|
|||||
|
2017
Q1 | $146M | Sell |
|
|||||
|
2016
Q4 | $122M | Buy |
|
|||||
|
2016
Q3 | $106M | Sell |
|
|||||
|
2016
Q2 | $134M | Buy |
|
|||||
|
2016
Q1 | $81.8M | Buy |
|
|||||
|
2015
Q4 | $120M | Buy |
|
|||||
|
2015
Q3 | $67.2M | Buy |
|
|||||
|
2015
Q2 | $82.6M | Sell |
|
|||||
|
2015
Q1 | $64.4M | Buy |
|
|||||
|
2014
Q4 | $44.2M | Sell |
|
|||||
|
2014
Q3 | $47.8M | Buy |
|
|||||
|
2014
Q2 | $34.8M | Buy |
|
|||||
|
2014
Q1 | $28.2M | Buy |
|
|||||
|
2013
Q4 | $1.89M | Buy |
|
|||||
|
2013
Q3 | $741K | Sell |
|
|||||
|
2013
Q2 | $771K | Buy |
|